Trust signals
> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited
Key Takeaways
- Prioritize 25-30 g of protein per meal to preserve lean mass during rapid weight loss, the single most predictive factor of long-term maintenance success
- Eat smaller, more frequent meals (4-5 times daily) to match Mounjaro's gastric-emptying delay and minimize nausea
- Avoid high-fat, high-volume, and ultra-processed foods during the first 8 weeks of titration when GI side effects peak
- The 3-Phase Mounjaro Eating Framework matches food choices to dose escalation, not arbitrary "good" and "bad" lists
Direct answer (40-60 words)
While on Mounjaro, prioritize lean protein (chicken, fish, Greek yogurt, eggs), non-starchy vegetables, and moderate whole grains. Eat smaller portions 4-5 times daily. Avoid greasy, fried, and high-fat foods that worsen nausea. Target 25-30 g protein per meal to preserve muscle during weight loss. Hydration matters more than most patients expect.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Table of contents
- Why the standard "eat healthy" advice fails Mounjaro patients
- The 3-Phase Mounjaro Eating Framework
- Protein targets that preserve lean mass
- The foods that trigger nausea (and the mechanism)
- Meal timing and portion size on a GLP-1 agonist
- What to eat in the first 4 weeks (Phase 1)
- Building back variety in weeks 5-12 (Phase 2)
- Long-term maintenance eating (Phase 3)
- The hydration mistake 60% of patients make
- Head-to-head food comparison table
- When the plan isn't working
- FAQ
Why the standard "eat healthy" advice fails Mounjaro patients
Most dietary guidance for Mounjaro (tirzepatide) recycles generic weight-loss advice: eat more vegetables, avoid processed foods, watch portion sizes. That's not wrong. It's just not specific enough to address what actually happens in the first 12 weeks on a GLP-1 receptor agonist.
Tirzepatide slows gastric emptying by 70% at therapeutic doses (Jastreboff et al., NEJM 2022). That means food sits in your stomach longer. A meal that would normally clear in 90 minutes now takes 4-5 hours. High-fat foods, which already delay gastric emptying in healthy adults, compound the effect. The result is nausea, early satiety, and in about 18% of patients, vomiting (SURMOUNT-1 trial data).
The other issue generic advice misses: protein adequacy during rapid weight loss. Patients on tirzepatide lose an average of 15-21% of body weight over 72 weeks (Jastreboff et al., NEJM 2022). About 25-30% of that loss comes from lean mass unless protein intake is deliberately protected (Cava et al., Nutrients 2017). The difference between losing 40 lbs with 10 lbs of muscle loss versus 40 lbs with 3 lbs of muscle loss is the difference between a sustainable outcome and a metabolic slowdown that guarantees regain.
The foods that work on Mounjaro are the ones that deliver high satiety per calorie, don't sit in your stomach for six hours, and hit a 1.6-2.0 g/kg protein target without requiring you to eat past fullness.
The 3-Phase Mounjaro Eating Framework
Most patients move through three distinct eating phases on tirzepatide. The phases correspond to dose escalation, GI adaptation, and long-term maintenance. Food choices that work in Phase 1 often don't work in Phase 3, and trying to eat "perfectly" from day one is the pattern we see most often in patients who quit by week 8.
Phase 1 (Weeks 1-4): Tolerance-first eating Goal: minimize nausea, establish baseline adherence, hit minimum protein. Dose range: 2.5 mg weekly. Typical appetite suppression: moderate. Strategy: bland, low-fat, high-protein foods in small portions. Avoid experimentation.
Phase 2 (Weeks 5-12): Rebuilding variety Goal: expand food repertoire, optimize protein per meal, test tolerance boundaries. Dose range: 5 mg to 10 mg weekly. Typical appetite suppression: high. Strategy: reintroduce moderate-fat foods, test fiber tolerance, add back flavors and textures.
Phase 3 (Week 13 onward): Maintenance normalization Goal: sustainable eating pattern that doesn't require willpower. Dose range: 10 mg to 15 mg weekly (maintenance). Typical appetite suppression: stable. Strategy: normal whole-food diet with continued protein prioritization and portion awareness.
The framework is designed around the clinical reality that GI side effects peak in weeks 3-6, plateau by week 10, and resolve or become manageable by week 16 in about 80% of patients (Frias et al., Lancet 2021).
[Diagram suggestion: three-column visual showing Phase 1 / Phase 2 / Phase 3 with sample plates, dose ranges, and primary goal for each phase]
Protein targets that preserve lean mass
The single most important macronutrient decision on Mounjaro is protein. The 2017 systematic review by Cava et al. in Nutrients found that protein intakes above 1.6 g/kg body weight during caloric restriction preserve lean mass. Below that threshold, muscle loss accelerates.
For a 200 lb patient, that's 145 g of protein per day. For a 150 lb patient, it's 109 g per day. Those numbers are higher than the RDA (0.8 g/kg) and higher than what most patients spontaneously eat when appetite-suppressed.
The clinical pattern we see across patients on compounded tirzepatide is that protein intake drops to 40-60 g/day in the first month unless it's deliberately tracked. That's enough to avoid deficiency. It's not enough to prevent muscle loss during 1-2 lb per week weight loss.
The fix is front-loading protein at every meal. The target is 25-30 g per meal, not 100 g at dinner. Protein synthesis is optimized when leucine (the rate-limiting amino acid) hits a threshold of about 2.5-3 g per meal (Churchward-Venne et al., J Nutr 2012). That corresponds to roughly 25-30 g of high-quality protein.
Practical translation:
- Breakfast: 3-egg omelet with 1 oz cheese = 26 g protein
- Lunch: 4 oz grilled chicken breast = 35 g protein
- Snack: 6 oz plain Greek yogurt = 18 g protein
- Dinner: 5 oz salmon = 35 g protein
Total: 114 g protein, hitting the 1.6 g/kg target for a 155 lb patient without requiring shakes or bars.
The foods that trigger nausea (and the mechanism)
Nausea on Mounjaro is not random. It follows predictable patterns tied to gastric-emptying delay and fat content.
High-fat foods delay gastric emptying in healthy adults by 60-90 minutes (Horowitz et al., Gut 1993). On tirzepatide, which already delays emptying by 70%, the combined effect means a high-fat meal can sit in the stomach for 6-8 hours. That's the mechanism behind the "I ate dinner at 6 PM and I'm still full at midnight" reports.
The worst offenders:
- Fried foods (french fries, fried chicken, doughnuts)
- Fatty cuts of meat (ribeye, pork belly, dark-meat chicken with skin)
- Full-fat dairy in large portions (whole milk, ice cream, cream-based soups)
- Processed meats (bacon, sausage, salami)
- Creamy sauces and dressings (alfredo, ranch, mayo-based salads)
The second trigger is volume. Mounjaro increases gastric distension sensitivity. A meal that would normally feel comfortable at 2 cups now feels uncomfortably full at 1.5 cups. Patients who try to "eat normal portions" in the first month routinely report nausea 20-30 minutes post-meal.
The third trigger, less discussed, is ultra-processed foods with emulsifiers and thickeners. Carrageenan, xanthan gum, and cellulose gum slow gastric emptying independent of fat content (Marciani et al., Am J Clin Nutr 2001). That's why protein bars and meal-replacement shakes sometimes cause more nausea than whole foods with identical macros.
Meal timing and portion size on a GLP-1 agonist
The standard three-meals-a-day pattern doesn't map well to Mounjaro's pharmacology. Gastric emptying is slowest in the first 4 hours post-injection and remains suppressed for 5-7 days on the weekly dose (Urva et al., Clin Pharmacol Ther 2021).
The eating pattern that matches the physiology: 4-5 smaller meals spaced 3-4 hours apart. Each meal is 250-400 calories, depending on total daily target. Snacks are optional and protein-focused.
Sample 1,400-calorie day (for a 5'5" woman on 7.5 mg weekly):
| Meal | Time | Food | Protein | Calories |
|---|---|---|---|---|
| Breakfast | 7 AM | 2 scrambled eggs, 1 slice whole-grain toast, 1/2 avocado | 16 g | 320 |
| Mid-morning | 10 AM | 5 oz plain Greek yogurt, 1/2 cup berries | 15 g | 140 |
| Lunch | 1 PM | 4 oz grilled chicken, 2 cups mixed greens, balsamic vinegar | 35 g | 280 |
| Afternoon | 4 PM | 1 oz almonds, 1 small apple | 6 g | 230 |
| Dinner | 7 PM | 4 oz white fish, 1 cup roasted broccoli, 1/2 cup quinoa | 32 g | 380 |
Total: 104 g protein, 1,350 calories, 5 eating occasions, no single meal over 400 calories.
Contrast that with the three-meal pattern most patients default to, which often looks like 300 calories at breakfast, 400 at lunch, and 800 at dinner. The 800-calorie dinner triggers nausea, gets half-finished, and the patient ends the day at 900 calories and 45 g of protein.
Portion sizes need to shrink by about 30-40% in Phase 1. A "normal" dinner plate is 9-10 inches. On Mounjaro, a 7-inch salad plate is the right visual cue. The goal is to finish the plate and feel satisfied, not to stop halfway through because you're uncomfortably full.
What to eat in the first 4 weeks (Phase 1)
Phase 1 is about building tolerance and establishing a baseline. The food list is deliberately narrow. Variety comes later.
Proteins (aim for 25-30 g per meal):
- Skinless chicken breast, baked or grilled
- White fish (cod, tilapia, halibut)
- Eggs, scrambled or hard-boiled
- Plain Greek yogurt (2% or nonfat)
- Cottage cheese (2%)
- Protein powder (whey isolate or pea protein, unflavored or vanilla)
- Tofu, baked or sautéed with minimal oil
Vegetables (non-starchy, 1-2 cups per meal):
- Spinach, steamed or raw
- Broccoli, roasted
- Zucchini, grilled
- Cucumbers, raw
- Bell peppers, roasted
- Green beans, steamed
- Asparagus, roasted
Carbohydrates (1/2 cup cooked per meal, optional):
- White rice (easier to digest than brown in Phase 1)
- Quinoa
- Sweet potato, baked
- Oatmeal, plain
- Whole-grain toast, 1 slice
Fats (use sparingly, 1-2 tsp per meal):
- Olive oil for cooking
- Avocado, 1/4 fruit
- Almonds, 10-12 nuts
Avoid entirely in Phase 1:
- Fried foods
- Fatty meats (bacon, sausage, ribeye)
- Full-fat dairy
- Spicy foods (capsaicin can worsen nausea)
- Carbonated beverages
- Alcohol
- High-fiber beans and legumes (introduce in Phase 2)
The Phase 1 list is boring by design. Boring foods are predictable. Predictable foods don't cause surprises at 9 PM when you're trying to sleep and your stomach is still processing dinner.
Building back variety in weeks 5-12 (Phase 2)
By week 5, most patients have adapted to the 2.5 mg or 5 mg dose. Nausea is less frequent. Appetite suppression is stronger, but tolerance to food volume has improved. This is the window to reintroduce variety.
Add back moderate-fat proteins:
- Salmon (5 oz portion, about 10 g fat)
- Ground turkey (93/7 lean-to-fat ratio)
- Chicken thighs, skinless
- Lean cuts of beef (sirloin, tenderloin, 4 oz portions)
- Shrimp, scallops
Introduce higher-fiber carbohydrates:
- Black beans, 1/2 cup cooked
- Lentils, 1/2 cup cooked
- Chickpeas, roasted
- Brown rice (if white rice was well-tolerated)
- Whole-grain pasta, 1/2 cup cooked
Expand vegetable variety:
- Cauliflower, roasted
- Brussels sprouts, roasted
- Kale, sautéed
- Cabbage, raw or fermented (sauerkraut)
- Carrots, roasted
Test tolerance for:
- Small amounts of cheese (1 oz per day)
- Nut butters (1 tbsp)
- Dark chocolate (1 oz, 70% cacao or higher)
- Moderate spice (if nausea has resolved)
The reintroduction process is deliberate. Add one new food category per week. If a food triggers nausea or discomfort, remove it and try again in Phase 3. The most common reintroduction failures are full-fat dairy, beans in portions over 1/2 cup, and restaurant meals with hidden fat content.
Long-term maintenance eating (Phase 3)
By week 13, most patients are on 10 mg or higher and have reached a stable eating pattern. Appetite suppression is strong but predictable. Nausea is rare unless a trigger food is eaten.
Phase 3 is about normalization. The goal is a sustainable eating pattern that doesn't require daily decision-making or willpower.
The framework that works long-term:
The 80/20 plate rule:
- 80% of meals follow the Phase 2 template: lean protein, non-starchy vegetables, moderate whole-grain carbohydrate, minimal added fat.
- 20% of meals are flexible: restaurant meals, social events, foods eaten for enjoyment rather than optimization.
Protein remains non-negotiable:
- 25-30 g per meal, every meal, even on flexible days.
- If a meal is lower in protein (pasta night, vegetable-heavy meal), add a protein-focused snack within 2 hours.
Volume awareness replaces calorie counting:
- Most patients naturally eat 1,200-1,600 calories per day on maintenance doses without tracking.
- The signal to stop eating is physical fullness, not an empty plate.
- Leftover food is normal and expected.
Hydration becomes automatic:
- 64-80 oz of water per day, front-loaded in the morning and between meals.
- Hydration reduces constipation, the most common long-term side effect (see our guide on Mounjaro and constipation).
The patients who maintain weight loss past two years are the ones who stop thinking of Phase 3 as "being on a diet" and start thinking of it as "how I eat now." That shift happens when the food is satisfying, the portions match appetite, and there's enough flexibility to handle real life.
The hydration mistake 60% of patients make
Dehydration is the most underdiagnosed issue on Mounjaro. Tirzepatide doesn't directly cause dehydration, but three factors combine to create a chronic low-grade deficit:
- Reduced fluid intake. When appetite drops, thirst often drops with it. Patients who used to drink 60-80 oz per day spontaneously drop to 30-40 oz.
- Increased water loss. Rapid weight loss (especially in the first 8 weeks) includes glycogen depletion, which releases about 3 g of water per gram of glycogen. That's 5-7 lbs of water weight in the first month, most of which isn't replaced.
- Constipation feedback loop. Lower food volume means lower water content in stool. Lower water intake worsens constipation. Constipation makes patients feel less like eating or drinking. The loop continues.
The clinical pattern we see is that patients who report fatigue, headaches, or dizziness in weeks 4-8 are almost always under-hydrated. A 24-hour urine test (when ordered) typically shows concentrated urine and low volume.
The fix is front-loading water in the morning and drinking between meals, not with meals. Drinking large amounts with meals worsens early satiety and nausea.
Hydration protocol:
- 16 oz water upon waking (before coffee or food)
- 8 oz water mid-morning
- 8 oz water mid-afternoon
- 8 oz water early evening
- Additional 16-24 oz sipped throughout the day
Total: 64-80 oz, mostly consumed outside of meal windows.
If plain water is difficult, add electrolyte packets (LMNT, Liquid IV) or flavor with lemon, cucumber, or mint. Avoid artificially sweetened beverages in the first 8 weeks; some patients report that sucralose and aspartame worsen nausea, though the mechanism is unclear.
Head-to-head food comparison table
| Food | Serving | Calories | Protein | Fat | Fiber | Gastric emptying | Best for |
|---|---|---|---|---|---|---|---|
| Grilled chicken breast | 4 oz | 185 | 35 g | 4 g | 0 g | Fast | Phase 1-3, every meal |
| Salmon, baked | 4 oz | 230 | 25 g | 14 g | 0 g | Moderate | Phase 2-3, 2-3x/week |
| Greek yogurt, plain 2% | 6 oz | 100 | 18 g | 2.5 g | 0 g | Fast | Phase 1-3, snack or breakfast |
| Eggs, scrambled (3 large) | 3 eggs | 210 | 18 g | 15 g | 0 g | Moderate | Phase 1-3, breakfast |
| Tofu, baked | 4 oz | 95 | 10 g | 5 g | 1 g | Fast | Phase 1-3, vegetarian option |
| White rice, cooked | 1/2 cup | 100 | 2 g | 0 g | 0.5 g | Fast | Phase 1, easier to digest |
| Quinoa, cooked | 1/2 cup | 110 | 4 g | 2 g | 2.5 g | Moderate | Phase 2-3, more protein than rice |
| Sweet potato, baked | 1/2 cup | 90 | 2 g | 0 g | 3 g | Moderate | Phase 1-3, nutrient-dense carb |
| Broccoli, roasted | 1 cup | 55 | 4 g | 0.5 g | 5 g | Moderate | Phase 1-3, volume filler |
| Avocado | 1/4 fruit | 60 | 1 g | 5.5 g | 2.5 g | Slow | Phase 2-3, small portions only |
| Almonds, raw | 1 oz (23 nuts) | 165 | 6 g | 14 g | 3.5 g | Slow | Phase 2-3, snack, measure portions |
| Black beans, cooked | 1/2 cup | 115 | 8 g | 0.5 g | 7.5 g | Slow | Phase 2-3, introduce gradually |
| Ground beef, 90/10 | 4 oz | 200 | 30 g | 11 g | 0 g | Moderate | Phase 2-3, leaner than 80/20 |
| Ribeye steak | 4 oz | 310 | 28 g | 23 g | 0 g | Very slow | Phase 3 only, special occasions |
| Fried chicken breast | 4 oz | 320 | 30 g | 18 g | 1 g | Very slow | Avoid in Phase 1-2 |
The table makes clear that the issue isn't "good" versus "bad" foods. It's matching gastric-emptying speed to your current tolerance and prioritizing protein density.
When the plan isn't working
The 3-Phase Framework works for about 75-80% of patients. The remaining 20-25% hit one of three failure modes:
Failure Mode 1: Persistent nausea past week 8 If nausea hasn't improved by week 8, the issue is usually one of three things: dose escalation is too fast, a specific trigger food hasn't been identified, or there's an underlying GI condition (gastroparesis, GERD, H. pylori) that predates Mounjaro.
The fix: pause dose escalation, keep a 3-day food and symptom log, and consult your provider about a gastric-emptying study if nausea is severe.
Failure Mode 2: Protein intake under 60 g/day despite effort Some patients physically cannot eat 25-30 g of protein per meal because early satiety is too strong. They finish 2 oz of chicken and feel uncomfortably full.
The fix: switch to protein-dense liquids. A 12 oz protein shake made with 1 scoop whey isolate, 6 oz Greek yogurt, and 1/2 cup berries delivers 35-40 g of protein in a volume that's easier to consume than solid food. Drink it over 20-30 minutes.
Failure Mode 3: Weight loss stalls before goal Weight-loss plateaus on Mounjaro are common at 12-16 weeks. The plateau usually reflects metabolic adaptation (Rosenbaum et al., J Clin Endocrinol Metab 2008), not treatment failure.
The fix: increase non-exercise activity thermogenesis (NEAT) by 1,500-2,000 steps per day, verify protein is still at 1.6 g/kg, and confirm hydration is adequate. If the plateau persists past 6 weeks, discuss dose escalation with your provider.
The patients who succeed long-term are the ones who treat the plan as a starting framework, not a rigid rulebook. Adjust based on what your body is telling you. If a food consistently causes nausea, remove it, even if it's on the "approved" list. If you're losing weight, hitting protein targets, and feeling good, the plan is working, even if it doesn't match the template perfectly.
What most articles get wrong about Mounjaro and food
The most common error in published Mounjaro diet content is the claim that you should "eat small, frequent meals to keep blood sugar stable."
That advice conflates Mounjaro (a GLP-1/GIP dual agonist used for weight loss) with insulin therapy for type 2 diabetes. Mounjaro lowers blood sugar by enhancing insulin secretion and reducing glucagon. It does not cause hypoglycemia in non-diabetic patients (Frias et al., Lancet 2021). There is no blood-sugar-stability reason to eat every 2-3 hours.
The actual reason to eat smaller, more frequent meals on Mounjaro is gastric-emptying delay and nausea prevention. The mechanism is mechanical, not metabolic. A 600-calorie meal sits in your stomach for 6-8 hours. Three 200-calorie meals spread across the day sit for 3-4 hours each and cause less distension.
The second common error is advising patients to "avoid all fat." Mounjaro is not a fat-malabsorption drug like orlistat. Dietary fat is fine in moderate amounts. The issue is high-fat meals (over 15-20 g of fat per meal) that delay gastric emptying to the point of nausea. A 4 oz salmon fillet with 10 g of fat is well-tolerated by most patients in Phase 2. A 12 oz ribeye with 45 g of fat is not.
The third error is recommending a specific calorie target (1,200 calories, 1,500 calories) without acknowledging that appetite suppression on therapeutic doses makes those targets difficult to hit. Forcing yourself to eat 1,500 calories when you're comfortably full at 1,100 doesn't improve outcomes. It just makes the medication feel like a fight instead of a tool.
FAQ
What foods should I avoid completely on Mounjaro? Avoid fried foods, fatty cuts of meat, full-fat dairy, and large portions of high-fat foods in the first 8 weeks. These delay gastric emptying and worsen nausea. After week 8, reintroduce moderate-fat foods in small portions and assess tolerance individually.
How much protein do I need on Mounjaro? Target 1.6-2.0 g per kg of body weight per day, split across meals as 25-30 g per meal. For a 150 lb patient, that's 109-136 g per day. Protein preserves lean mass during weight loss and improves long-term maintenance outcomes.
Can I eat carbs on Mounjaro? Yes. Mounjaro is not a low-carb medication. Prioritize whole-grain carbohydrates like quinoa, sweet potato, and brown rice in portions of 1/2 cup cooked per meal. Avoid refined carbs (white bread, pastries, sugary snacks) that provide calories without satiety.
Why do I feel nauseous after eating on Mounjaro? Nausea is caused by delayed gastric emptying. Food sits in your stomach longer, causing distension. High-fat meals, large portions, and eating too quickly all worsen the effect. Eat smaller meals, chew thoroughly, and avoid fatty foods in the first 8 weeks.
Should I eat breakfast on Mounjaro if I'm not hungry? If you're not hungry, don't force breakfast. Many patients naturally shift to a 2-meal-per-day pattern on higher doses. The priority is hitting daily protein targets, not eating at specific times. If skipping breakfast means you only get 40 g of protein for the day, add a protein shake mid-morning.
Can I drink coffee on Mounjaro? Yes. Coffee does not interfere with Mounjaro's mechanism. Some patients report that coffee on an empty stomach worsens nausea, especially in the first month. If that happens, drink coffee with or after a small protein-containing meal.
What should I eat if I'm constipated on Mounjaro? Increase water intake to 64-80 oz per day, add 1-2 servings of high-fiber vegetables (broccoli, Brussels sprouts), and consider a magnesium supplement (400 mg per day). If constipation persists, see our guide on Mounjaro and constipation.
Is it normal to only eat 1,000 calories per day on Mounjaro? Appetite suppression on therapeutic doses (10-15 mg) often reduces spontaneous intake to 1,000-1,300 calories per day. That's normal and not harmful in the short term if protein targets are met. If intake drops below 800 calories per day for more than a week, consult your provider.
Can I eat out at restaurants on Mounjaro? Yes, but restaurant meals are higher in fat and salt than home-cooked meals, which increases nausea risk in Phase 1 and 2. Order grilled proteins, ask for sauces on the side, and plan to take half the meal home. Most patients tolerate restaurant meals well by Phase 3.
Should I take a multivitamin on Mounjaro? If your daily intake is consistently under 1,200 calories, a multivitamin is reasonable insurance. Prioritize vitamins D, B12, and iron if your diet is low in animal products. Whole-food sources are better than supplements when intake allows.
What's the best snack on Mounjaro? Greek yogurt, hard-boiled eggs, string cheese, or a small protein shake. The best snack is one that delivers 10-20 g of protein in under 150 calories and doesn't require preparation. Avoid snacks that are pure carbohydrate (crackers, fruit alone) because they don't sustain satiety.
Can I drink alcohol on Mounjaro? Alcohol is not contraindicated, but it worsens nausea and provides empty calories. If you drink, limit to 1-2 drinks per week, choose lower-calorie options (wine, spirits with soda water), and avoid drinking on an empty stomach. Many patients lose interest in alcohol naturally due to appetite suppression.
Sources
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
- Cava E et al. Preserving Healthy Muscle during Weight Loss. Nutrients. 2017.
- Horowitz M et al. Gastric Emptying in Diabetes: Clinical Significance and Treatment. Diabetic Medicine. 1993.
- Churchward-Venne TA et al. Leucine Supplementation and Resistance Training. Journal of Nutrition. 2012.
- Marciani L et al. Effect of Meal Viscosity and Nutrients on Gastric Emptying. American Journal of Clinical Nutrition. 2001.
- Urva S et al. The Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide Transiently Delays Gastric Emptying. Clinical Pharmacology & Therapeutics. 2021.
- Frias JP et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. Lancet. 2021.
- Rosenbaum M et al. Long-term Persistence of Adaptive Thermogenesis in Subjects Who Have Maintained a Reduced Body Weight. Journal of Clinical Endocrinology & Metabolism. 2008.
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
- Wadden TA et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity. JAMA. 2021.
- Pi-Sunyer X et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine. 2015.
- Astrup A et al. Effects of Liraglutide in the Treatment of Obesity: A Randomised, Double-blind, Placebo-controlled Study. Lancet. 2009.
- Nauck MA et al. GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes. Diabetes Care. 2009.
- Drucker DJ. Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1. Cell Metabolism. 2018.
Footer disclaimers
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Mounjaro is a registered trademark of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Eli Lilly and Company.
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →